Hawkins, Inc. Reports Second Quarter Fiscal 2024 Results

Rhea-AI Summary

Hawkins, Inc. announces strong second-quarter results with sales of $236.5 million, a 17% increase in Water Treatment group sales, and record quarterly gross profit of $53.9 million. Diluted EPS for the quarter is $1.10, a 28% increase from the previous year. The company also reduced its debt to $60.0 million and added six Water Treatment locations through acquisitions.

Positive

• Second quarter sales of $236.5 million, a 17% increase in Water Treatment group sales, and record quarterly gross profit of $53.9 million showcase strong financial performance.
• Diluted EPS for the quarter is $1.10, a 28% increase from the same period last year, demonstrating significant earnings growth.
• The company reduced its debt to $60.0 million and achieved a leverage ratio of 0.45x adjusted EBITDA, indicating improved financial stability.
• Acquisitions of Water Solutions Unlimited, Inc. and The Miami Products & Chemical Company added six Water Treatment locations, expanding the company's presence.
• The Industrial group experienced a decline in sales, but operating income increased by 2%.
• The Health and Nutrition group saw a slowdown in the year-over-year sales decline during the second quarter.

Negative

• None.

ROSEVILLE, Minn., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Hawkins, Inc. (Nasdaq: HWKN) today announced results for the three and six months ended October 1, 2023, its second quarter of fiscal 2024.

Second Quarter Fiscal Year 2024 Highlights:

• Second quarter sales of $236.5 million, with Water Treatment group sales growth of 17% over the same quarter in the prior year.
• Record quarterly gross profit of $53.9 million, a 16% increase over the prior year, contributing to record quarterly operating income of $33.0 million, a 25% year-over-year increase.
• Record second quarter diluted earnings per share ("EPS") of $1.10, 28% higher than the same period last year.
• Record quarterly earnings before interest, taxes, depreciation and amortization ("EBITDA"), a non-GAAP measure, of $41.5 million, a 22% increase over the same period of the prior year.
• Record quarterly operating cash flow of $57.8 million, a portion of which was used to pay down $28.6 million on our revolving line of credit, reducing our debt to $60.0 million and bringing our leverage ratio to 0.45x adjusted EBITDA.
• Year-to-date diluted EPS of $2.22 grew 24% over the prior year.
• After quarter-end, added six Water Treatment locations through acquisitions of Water Solutions Unlimited, Inc. and The Miami Products & Chemical Company.
  
  

Executive Commentary – Patrick H. Hawkins, Chief Executive Officer and President:

“We are pleased with our strong year-over-year performance in the second quarter, with our bottom line growing 29%, following our strong first-quarter growth of 19%. Our Water Treatment group once again led the way with revenue growth of 17% and operating income growth of nearly 70%. We continue to see profit growth within this segment, as we execute on our strategy to grow both the legacy business and the businesses we have acquired over the last few years. Although our Industrial group sales declined year-over-year, operating income was up 2%. In addition, the year-over-year second quarter sales decline in our Health and Nutrition group slowed to about half of what it was in the first quarter, showing signs of improvement."

Mr. Hawkins continued, "The strong first-half results, combined with disciplined inventory management, allowed us to pay down $52 million on our debt in the first six months of the year. Our strong financial position has allowed us to continue our strategy of Water Treatment growth as we added six additional locations through two acquisitions after quarter-end. We expect continued growth in our Water Treatment segment for the remainder of the year, remain cautiously optimistic about our Industrial segment, and expect the Health and Nutrition distribution business to improve on a year-over-year basis beginning in calendar 2024. With the diversity of our businesses and the overall strength of our Company, we believe we will continue to generate strong operating cash flow and will continue to manage our balance sheet during the remainder of the fiscal year."

Second Quarter Financial Highlights:

NET INCOME

For the second quarter of fiscal 2024, the Company reported net income of $23.2 million, or $1.10 per diluted share, compared to net income for the second quarter of fiscal 2023 of $18.0 million, or $0.86 per diluted share.

REVENUE

Sales were $236.5 million for the second quarter of fiscal 2024, a decrease of $4.7 million, or 2%, from sales of $241.2 million in the same period a year ago. Decreased sales in our Industrial and Health and Nutrition segments more than offset increased sales in our Water Treatment segment. Industrial segment sales decreased $15.4 million, or 14%, to $98.5 million for the current quarter, from $113.9 million in the same period a year ago. The sale of our consumer bleach packaging business at the end of fiscal 2023 resulted in $4.0 million lower sales in the current quarter. In addition, Industrial segment sales declined due to overall lower volumes. Water Treatment segment sales increased $14.4 million or 17%, to $100.9 million for the current quarter, from $86.5 million in the same period a year ago. Water Treatment sales increased as a result of increased selling prices on many of our products as well as increased sales volumes of certain of our products. Health and Nutrition segment sales decreased $3.7 million, or 9%, to $37.1 million for the current quarter, from $40.8 million in the same period a year ago. Health and Nutrition segment sales decreased primarily due to lower demand from our customers, which we believe was driven by excess inventory at some of our customers as well as lower consumer demand for health and immunity products. The sales decline experienced in the second quarter of fiscal 2023 was about half the decline experienced in the first quarter of fiscal 2023.

GROSS PROFIT

Gross profit increased $7.5 million, or 16%, to $53.9 million, or 23% of sales, for the current quarter, from $46.4 million, or 19% of sales, in the same period a year ago. During the current quarter, the LIFO reserve decreased, and gross profit increased, by $3.2 million due primarily to decreasing raw material prices. In the same quarter a year ago, the LIFO reserve increased, and gross profit decreased, by $5.3 million due primarily to rising raw material prices. Gross profit for the Industrial segment increased $0.1 million, or 1%, to $17.8 million, or 18% of sales, for the current quarter, from $17.7 million, or 16% of sales, in the same period a year ago. Industrial segment gross profit increased slightly due to improved unit margins on certain products. Gross profit for the Water Treatment segment increased $8.8 million, or 43%, to $29.3 million, or 29% of sales, for the current quarter, from $20.5 million, or 24% of sales, in the same period a year ago. Water Treatment segment gross profit increased as a result of improved per-unit margins on many of our products as well as increased sales. Gross profit for our Health and Nutrition segment decreased $1.5 million, or 18%, to $6.7 million, or 18% of sales, for the current quarter, from $8.2 million, or 20% of sales, in the same period a year ago. Health and Nutrition segment gross profit decreased as a result of lower sales and lower per-unit margins on certain products.

SELLING, GENERAL AND ADMINISTRATIVE EXPENSES

Selling, general and administrative expenses increased $1.1 million, or 6%, to $20.9 million, or 9% of sales, for the current quarter, from $19.8 million, or 8% of sales, in the same period a year ago. Expenses increased largely due to increased variable pay as well as added costs from acquired businesses.

ADJUSTED EBITDA

Adjusted EBITDA, a non-GAAP financial measure, is an important performance indicator and a key compliance measure under the terms of our credit agreement. An explanation of the computation of adjusted EBITDA is presented below. Adjusted EBITDA for the three months ended October 1, 2023 was $41.5 million, an increase of $7.5 million, or 22%, from $34.0 million in the same period a year ago.

INCOME TAXES

Our effective income tax rate was 27% for both the current quarter and the same period a year ago. The effective tax rate is impacted by projected levels of annual taxable income, permanent items, and state taxes. Our effective tax rate for the full year is currently expected to be approximately 26-27%.

BALANCE SHEET

During the second quarter, our working capital demands decreased in large part due to favorable cash collections on accounts receivable and disciplined management of our inventory levels. This improvement, along with higher net income, allowed us to reduce our debt by $28.6 million in the quarter and $52 million year to date. We now have total outstanding debt of $60 million, which is 0.45x our trailing twelve-month adjusted EBITDA, down from 0.96x at the end of fiscal 2023.

About Hawkins, Inc.

Hawkins, Inc. was founded in 1938 and is a leading specialty chemical and ingredients company that formulates, distributes, blends, and manufactures products for its Industrial, Water Treatment, and Health & Nutrition customers. Headquartered in Roseville, Minnesota, the Company has 58 facilities in 26 states and creates value for its customers through superb customer service and support, quality products and personalized applications. Hawkins, Inc. generated $935 million of revenue in fiscal 2023 and has approximately 950 employees. For more information, including registering to receive email alerts, please visit www.hawkinsinc.com/investors.

Reconciliation of Non-GAAP Financial Measures

We report our consolidated financial results in accordance with U.S. generally accepted accounting principles (GAAP). To assist investors in understanding our financial performance between periods, we have provided certain financial measures not computed according to GAAP, including adjusted EBITDA. This non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP measures. The method we use to produce non-GAAP results is not computed according to GAAP and may differ from the methods used by other companies.

Management uses this non-GAAP financial measure internally to understand, manage and evaluate our business and to make operating decisions. Management believes that this non-GAAP financial measure reflects an additional way of viewing aspects of our operations that, when viewed with our GAAP results, provides a more complete understanding of the factors and trends affecting our financial condition and results of operations.

We define adjusted EBITDA as GAAP net income adjusted for the impact of the following: net interest expense resulting from our net borrowing position; income tax expense; non-cash expenses including amortization of intangibles, depreciation and charges for the employee stock purchase plan and restricted stock grants; and non-recurring items of income or expense, if applicable.

Adjusted EBITDA	Three Months Ended								Six months ended
(In thousands)	October 1, 2023				October 2, 2022				October 1, 2023				October 2, 2022
Net Income (GAAP)	$	23,216			$	18,000			$	46,646			$	37,695
Interest expense, net		717				1,383				1,865				2,312
Income tax expense		8,769				6,707				17,015				13,184
Amortization of intangibles		1,724				1,749				3,394				3,506
Depreciation expense		5,675				5,064				11,112				9,865
Non-cash compensation expense		1,260				1,085				2,219				1,680
Non-recurring acquisition expenses		122				—				122				—
Adjusted EBITDA	$	41,483			$	33,988			$	82,373			$	68,242

HAWKINS, INC.
CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
(In thousands, except share and per-share data)
	Three Months Ended								Six Months Ended
	October 01, 2023				October 02, 2022				October 01, 2023				October 02, 2022
Sales	$	236,526			$	241,192			$	487,646			$	487,735
Cost of sales		(182,640	)			(194,818	)			(381,769	)			(394,612	)
Gross profit		53,886				46,374				105,877				93,123
Selling, general and administrative expenses		(20,895	)			(19,838	)			(40,399	)			(38,723	)
Operating income		32,991				26,536				65,478				54,400
Interest expense, net		(717	)			(1,383	)			(1,865	)			(2,312	)
Other (expense) income		(289	)			(446	)			48				(1,209	)
Income before income taxes		31,985				24,707				63,661				50,879
Income tax expense		(8,769	)			(6,707	)			(17,015	)			(13,184	)
Net income	$	23,216			$	18,000			$	46,646			$	37,695
Weighted average number of shares outstanding - basic		20,903,690				20,814,686				20,905,707				20,861,754
Weighted average number of shares outstanding - diluted		21,026,428				20,956,897				21,034,153				21,004,454
Basic earnings per share	$	1.11			$	0.86			$	2.23			$	1.81
Diluted earnings per share	$	1.10			$	0.86			$	2.22			$	1.79
Cash dividends declared per common share	$	0.16			$	0.14			$	0.31			$	0.28

HAWKINS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(In thousands, except share data)
			October 1, 2023				April 2, 2023
ASSETS
CURRENT ASSETS:
	Cash and cash equivalents		$	10,974			$	7,566
	Trade accounts receivables, net			124,813				129,252
	Inventories			68,500				88,777
	Prepaid expenses and other current assets			2,966				6,449
		Total current assets		207,253				232,044
PROPERTY, PLANT, AND EQUIPMENT:				361,362				344,753
	Less accumulated depreciation			168,504				158,950
		Net property, plant, and equipment		192,858				185,803
OTHER ASSETS:
	Right-of-use assets			11,323				10,199
	Goodwill			77,401				77,401
	Intangible assets, net of accumulated amortization			71,491				73,060
	Deferred compensation plan asset			8,917				7,367
	Other			6,054				4,661
		Total other assets		175,186				172,688
		Total assets	$	575,297			$	590,535
LIABILITIES AND SHAREHOLDERS’ EQUITY
CURRENT LIABILITIES:
	Accounts payable — trade		$	61,192			$	53,705
	Accrued payroll and employee benefits			12,416				17,279
	Income tax payable			4,319				3,329
	Current portion of long-term debt			9,913				9,913
	Other current liabilities			6,622				6,645
		Total current liabilities		94,462				90,871
LONG-TERM DEBT, LESS CURRENT PORTION				49,775				101,731
LONG-TERM LEASE LIABILITY				9,522				8,687
PENSION WITHDRAWAL LIABILITY				3,726				3,912
DEFERRED INCOME TAXES				24,190				23,800
DEFERRED COMPENSATION LIABILITY				10,317				9,343
OTHER LONG-TERM LIABILITIES				649				2,175
		Total liabilities		192,641				240,519
COMMITMENTS AND CONTINGENCIES
SHAREHOLDERS’ EQUITY:
	Common stock; authorized: 60,000,000 shares of $0.01 par value; 20,787,626 and 20,850,454 shares issued and outstanding as of October 1, 2023 and April 2, 2023, respectively			208				209
	Additional paid-in capital			35,918				44,443
	Retained earnings			342,535				302,424
	Accumulated other comprehensive income			3,995				2,940
		Total shareholders’ equity		382,656				350,016
		Total liabilities and shareholders’ equity	$	575,297			$	590,535

HAWKINS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
(In thousands)
					Six Months Ended
					October 1, 2023				October 2, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
	Net income				$	46,646			$	37,695
	Reconciliation to cash flows:
		Depreciation and amortization				14,506				13,371
		Operating leases				1,115				945
		(Gain) loss on deferred compensation assets				(48	)			1,208
		Stock compensation expense				2,219				1,680
		Other				(34	)			187
		Changes in operating accounts providing (using) cash:
			Trade receivables			4,909				(8,481	)
			Inventories			20,752				(18,077	)
			Accounts payable			6,421				(4,609	)
			Accrued liabilities			(7,149	)			(8,600	)
			Lease liabilities			(1,127	)			(972	)
			Income taxes			990				2,031
			Other			3,430				2,425
				Net cash provided by operating activities		92,630				18,803
CASH FLOWS FROM INVESTING ACTIVITIES:
	Purchases of property, plant, and equipment					(16,922	)			(20,668	)
	Acquisitions					(3,355	)			—
	Other					335				296
				Net cash used in investing activities		(19,942	)			(20,372	)
CASH FLOWS FROM FINANCING ACTIVITIES:
	Cash dividends declared and paid					(6,535	)			(5,900	)
	New shares issued					1,147				1,004
	Payroll taxes paid in exchange for shares withheld					(2,140	)			(1,550	)
	Shares repurchased					(9,752	)			(6,557	)
	Payments on revolving loan					(52,000	)			(30,000	)
	Proceeds from revolving loan borrowings					—				45,000
				Net cash (used in) provided by financing activities		(69,280	)			1,997
NET INCREASE IN CASH AND CASH EQUIVALENTS						3,408				428
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD						7,566				3,496
CASH AND CASH EQUIVALENTS, END OF PERIOD					$	10,974			$	3,924
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION
	Cash paid for income taxes				$	16,025			$	11,148
	Cash paid for interest				$	2,002			$	1,879
	Noncash investing activities - capital expenditures in accounts payable				$	2,970			$	2,535

HAWKINS, INC.
REPORTABLE SEGMENTS (UNAUDITED)
(In thousands)
	Industrial				Water Treatment				Health and Nutrition				Total
Three months ended October 1, 2023:
Sales	$	98,535			$	100,925			$	37,066			$	236,526
Gross profit		17,844				29,308				6,734				53,886
Selling, general, and administrative expenses		6,806				10,145				3,944				20,895
Operating income		11,038				19,163				2,790				32,991
Three months ended October 2, 2022:
Sales	$	113,939			$	86,488			$	40,765			$	241,192
Gross profit		17,713				20,504				8,157				46,374
Selling, general, and administrative expenses		6,891				9,082				3,865				19,838
Operating income		10,822				11,422				4,292				26,536
Six months ended October 1, 2023:
Sales	$	219,408			$	194,576			$	73,662			$	487,646
Gross profit		37,150				55,716				13,011				105,877
Selling, general and administrative expenses		13,381				19,271				7,747				40,399
Operating income		23,769				36,445				5,264				65,478
Six months ended October 2, 2022:
Sales	$	238,649			$	164,978			$	84,108			$	487,735
Gross profit		37,722				39,457				15,944				93,123
Selling, general and administrative expenses		13,276				17,783				7,664				38,723
Operating income		24,446				21,674				8,280				54,400

Forward-Looking Statements. Various remarks in this press release constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include those relating to consumer demand for products containing our ingredients and the impacts of those demands, expectations for results in our business segments and the timing of our filings with the Securities and Exchange Commission. These statements are not historical facts, but rather are based on our current expectations, estimates and projections, and our beliefs and assumptions. Forward-looking statements may be identified by terms, including “anticipate,” “believe,” “can,” “could,” “expect,” “intend,” “may,” “predict,” “should,” or “will” or the negative of these terms or other comparable terms. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. Actual results may vary materially from those contained in forward looking statements based on a number of factors, including, but not limited to, changes in regulation, changes in the labor markets, changes in competition and price pressures, changes in demand and customer requirements or processes for our products, availability of product and disruptions to supplies, interruptions in production resulting from hazards, transportation limitations or other extraordinary events outside our control that may negatively impact our business or the supply chains in which we participate, changes in imported products and tariff levels, the availability of products and the prices at which they are available, the acceptance of new products by our customers and the timing of any such acceptance, and changes in product supplies. Additional information concerning potential factors that could affect future financial results is included in our Annual Report on Form 10-K for the fiscal year ended April 2, 2023, as updated from time to time in amendments and subsequent reports filed with the SEC. Investors should take such risks into account when making investment decisions. Shareholders and other readers are cautioned not to place undue reliance on forward-looking statements, which reflect our management’s view only as of the date hereof. We do not undertake any obligation to update any forward-looking statements.

Contacts:	Jeffrey P. Oldenkamp
	Executive Vice President and Chief Financial Officer
	612/331-6910
	ir@HawkinsInc.com

FAQ

What were Hawkins, Inc.'s second quarter sales?

Hawkins, Inc. reported second quarter sales of $236.5 million.

What was the growth rate of Water Treatment group sales in the second quarter?

Water Treatment group sales grew by 17% in the second quarter.

What was the record quarterly gross profit for Hawkins, Inc.?

Hawkins, Inc. achieved a record quarterly gross profit of $53.9 million.

What was the diluted EPS for the second quarter?

The diluted EPS for the second quarter was $1.10.

How much debt did Hawkins, Inc. reduce?

Hawkins, Inc. reduced its debt to $60.0 million.

How many Water Treatment locations did Hawkins, Inc. acquire?

Hawkins, Inc. added six Water Treatment locations through acquisitions.

What was the operating income growth for the Water Treatment group?

The operating income for the Water Treatment group grew by nearly 70%.

Did the Industrial group experience growth in operating income?

Although the Industrial group had a decline in sales, operating income increased by 2%.